FibroGen Current Deferred Revenue (Quarterly) Analysis

FibroGen, Inc. (FGEN)

8.72 -0.06 (-0.68%) USD | NASDAQ | Dec 30, 16:00

8.70 -0.02 (-0.23%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for FGEN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	--
Theravance Biopharma, Inc.	--
Myomo, Inc.	Upgrade